J. Singh, “Ceftobiprole medocaril (Zevtera) – FDA approved antibiotic for three infections including methicillin-resistant Staphylococcus aureus”, J. Mol. Chem., vol. 4, no. 2, p. 692, Apr. 2024, doi: 10.62110/sciencein.jmc.2024.692.